Gozariu-Strîmbu M, Care A D, Cooper C W, Orbai P, Barabaş A T, Gozariu L
Dept. of Endocrinology, I.M.F. Cluj-Napoca.
Endocrinologie. 1990 Jul-Dec;28(3-4):155-8.
The presence of calcitonin gene-related peptide (CGRP) in both C-cells and nerve fibres around the thyroid blood vessels and follicles suggests that it may play a dual role, one of which may be in hormone secretion. Beta-CGRP injected intracerebroventricularly (icv) (1.875 nmol) caused a significant increase in the calcitonin CT) content of the C-cells in rat thyroid glands. The calcitonin content of the thyroids was determined by a radioimmunoassay using two antibodies and the results were expressed as ng CT/mg of fetal tissue. A significant rise in CT content of the thyroids occurred (5.5 +/- 0.5 n = 6), compared with the controls (3.5 +/- 0.1 n = 6). It is presumed that this change reflects an increase in the rate of secretion of CT in the thyroid glands of those rats so treated. The peptide might act on the central nervous system to stimulate the catecholamine outflow from the thyroid nerves and thereby increase the secretion rate of CT.
降钙素基因相关肽(CGRP)存在于甲状腺血管和滤泡周围的C细胞及神经纤维中,这表明它可能发挥双重作用,其中之一可能与激素分泌有关。脑室内注射(icv)β-CGRP(1.875纳摩尔)可使大鼠甲状腺C细胞中的降钙素(CT)含量显著增加。采用两种抗体通过放射免疫分析法测定甲状腺的降钙素含量,结果以每毫克胎儿组织中CT的纳克数表示。与对照组(3.5±0.1,n = 6)相比,甲状腺CT含量显著升高(5.5±0.5,n = 6)。据推测,这种变化反映了经如此处理的大鼠甲状腺中CT分泌速率的增加。该肽可能作用于中枢神经系统,刺激甲状腺神经中儿茶酚胺的释放,从而提高CT的分泌速率。